A bill to amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of all contact lenses as medical devices, and for other purposes.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
96pct
287d open
vs 4,105 other S bills in the 109th — cohort avg 35d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (2)
2005 · mid_year · Health Issues
HR 371 HR 525 HR 801 HR 2238 HR 2744 HR 3010 S 172 S 1955
Client expense: $294,643 · Firm income: Not reported
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2005 · mid_year · Health Issues
HR 525 HR 371 HR 2238 HR 5006 HR 3205 HR 1313 S 172 S 1081 S 1355 S 2810
Client expense: $491,294 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R.2218 Regulation of non corrective contact lens as medical devices S.930 Food and Drug Administration Safety Act of 2005 H.R.2090 Food and Drug Administration Improvement Act of 2005 H.R.3196 - Fair Access to Clinical Trials Act S. 470 - FACT Act H.R.3428 - OTC Medicine Tax Fairness Act of 2005 S.1514 - OTC Medicine Tax Fairness Act of 2005 S.172 - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of all contact lenses as medical devices, and for other purposes. H.R.371 - To amend the Federal Food, Drug, and Cosmetic Act to provide for the regulation of all contact lenses as medical devices, and for other purposes. S.103 - Combat Meth Act of 2005 H.R.314 - Combat Meth Act of 2005 S.950 Elimination of Neglected Diseases Act of 2005 H.R.3057 Dept. of State, Foreign Operations, and Related Programs Appropriations Act, 2006 Drug Importation Medicare Part B and Part D Sickle Cell Anemia Immunosuppressant Legislation Cancer Therapies Legislation Gene Therapy Direct to Consumer Advertising Medicare Prescription Drugs & Modernization Act
Client expense: $1,841,931 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Agency for International Development (USAID)
| Republican |
| KY |
| Jon Corzine | Democratic | NJ |
| Michael B. Enzi | Republican | WY |
| Richard Burr | Republican | NC |
| Susan M. Collins | Republican | ME |
| Tom Harkin | Democratic | IA |